Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-21-052824

Chief Financial Officer sold 33,000 shares at an average $16.88 ($557,023)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Alam Kamran Chief Financial Officer 2021-08-18 Sale −11,193 $17.35 $194,199 319,928 D
Alam Kamran Chief Financial Officer 2021-08-19 Sale −9,354 $16.43 $153,686 310,574 D
Alam Kamran Chief Financial Officer 2021-08-19 Sale −613 $17.11 $10,488 309,961 D
Alam Kamran Chief Financial Officer 2021-08-20 Sale −9,746 $16.70 $162,758 300,215 D
Alam Kamran Chief Financial Officer 2021-08-20 Sale −2,094 $17.14 $35,891 298,121 D
Open-market sales · 33,000 sh · avg $16.88 · $557,023
Loading xslF345X03/doc4.xml…